Applied Imaging subject to Nasdaq-delisting
This article was originally published in Clinica
Executive Summary
Applied Imaging could face being delisted from Nasdaq after failing to file its quarterly report for the period ended September 30 2004 with the US Securities and Exchange Commission. The company's appeal against the delisting is under review by the Nasdaq Listing Qualifications Panel. Until the final determination, the date of which is not known, the company's shares will be traded under an amended trading symbol.